Home›People›Carlo Traverso
Carlo Traverso

Carlo Traverso

Co-founder, scientific advisor and director at SUTOL Bio

Director
Updated Nov 10, 2026·Latest SEC filing Nov 10, 2026·Suggest an edit

About Carlo Traverso

Traverso is a director, co-founder and scientific advisor at SUTOL Bio. The company develops a capsule that stays in the stomach and releases medicine continuously for more than 30 days. He directs the Laboratory for Translational Engineering and is an associate professor of mechanical engineering at MIT. He also practices gastroenterology at Brigham and Women's Hospital and is an associate member of the Broad Institute. His work spans drug delivery, swallowable and implantable medical devices, and diagnostics.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Carlo Traverso in the role, so the role may have started earlier or lasted longer.

Sutol Bio, Inc. Current
Co-Founder & Scientific Advisor, director
2026 – Present · Cambridge, MA
SUTOL Bio develops a stomach-resident capsule that releases medicine continuously for more than 30 days.
Laboratory for Translational Engineering Current
Director
MIT Current
Associate Professor of Mechanical Engineering
Brigham and Women's Hospital Current
gastroenterologist
Broad Institute Current
Associate Member

Key Colleagues at Startups

The people Carlo Traverso works with at each company, as listed on that company's latest Form D.

Sutol Bio, Inc. · Form D, Nov 10, 2026
Seungho Lee
Seungho Lee
Co-Founder & CEO, director
Matt Murphy
Matt Murphy
Co-Founder & Chief Engineer, director
Robert Langer
Robert Langer
Co-Founder & Scientific Advisor, director

Sources

  1. SECSutol Bio, Inc. Form D, filed Nov 10, 2026
  2. P1SUTOL Bio home page